ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 versus 12 months of clopidogrel therapy after drug-eluting stenting . Eur Heart J 2015; 36 :1252–1263.Mathias HC, Ozalp F, Will MB, et al. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitori...
Methods: ISAR-SAFE is a randomized, double-blind, multicenter trial comparing 6 versus 12 months of clopidogrel therapy duration in patients with DES implantation. Patients were enrolled at 6 months after DES implantation and randomly assigned to either 6 further months of clopidogrel therapy or ...
Six vs. 12 months of clopidogrel therapy after DES in patients with ACS: a subgroup analysis of the ISAR-SAFE studyJonathan Michel